Bank of Montreal Can Raises Position in Humana Inc. $HUM

Bank of Montreal Can grew its position in Humana Inc. (NYSE:HUM) by 4.4% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 149,773 shares of the insurance provider’s stock after buying an additional 6,349 shares during the period. Bank of Montreal Can owned approximately 0.12% of Humana worth $36,617,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the company. Cary Street Partners Investment Advisory LLC raised its holdings in Humana by 63.9% in the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock worth $31,000 after buying an additional 46 shares during the last quarter. Applied Finance Capital Management LLC raised its holdings in Humana by 1.7% in the first quarter. Applied Finance Capital Management LLC now owns 2,943 shares of the insurance provider’s stock worth $779,000 after buying an additional 48 shares during the last quarter. Blue Trust Inc. raised its holdings in Humana by 3.6% in the second quarter. Blue Trust Inc. now owns 1,367 shares of the insurance provider’s stock worth $334,000 after buying an additional 48 shares during the last quarter. Atlas Brown Inc. raised its holdings in Humana by 0.9% in the second quarter. Atlas Brown Inc. now owns 6,369 shares of the insurance provider’s stock worth $1,557,000 after buying an additional 54 shares during the last quarter. Finally, Townsquare Capital LLC raised its holdings in Humana by 2.8% in the first quarter. Townsquare Capital LLC now owns 2,255 shares of the insurance provider’s stock worth $597,000 after buying an additional 61 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts have issued reports on HUM shares. The Goldman Sachs Group assumed coverage on shares of Humana in a report on Tuesday, October 14th. They issued a “sell” rating and a $235.00 target price for the company. Royal Bank Of Canada lifted their price target on shares of Humana from $283.00 to $322.00 and gave the stock an “outperform” rating in a research note on Thursday, August 21st. Wolfe Research lifted their price target on shares of Humana from $283.00 to $313.00 and gave the stock an “outperform” rating in a research note on Monday, October 6th. Piper Sandler reduced their price target on shares of Humana from $288.00 to $272.00 and set a “neutral” rating for the company in a research note on Thursday, July 31st. Finally, Mizuho lifted their price target on shares of Humana from $300.00 to $345.00 and gave the stock an “outperform” rating in a research note on Thursday, October 9th. Eight research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, Humana has an average rating of “Hold” and a consensus price target of $299.22.

Humana Stock Performance

Shares of NYSE HUM opened at $265.48 on Thursday. The firm has a 50 day moving average of $280.01 and a 200 day moving average of $258.90. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. The firm has a market capitalization of $31.93 billion, a price-to-earnings ratio of 20.37, a price-to-earnings-growth ratio of 1.71 and a beta of 0.42. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $315.35.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.95 by $0.29. The company had revenue of $32.65 billion during the quarter, compared to analyst estimates of $31.99 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. The firm’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same period in the previous year, the business posted $4.16 earnings per share. On average, research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.3%. The ex-dividend date is Friday, December 26th. Humana’s payout ratio is 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.